Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
-
ApolloMD Welcomes Scott O’Neil to Strategic Advisory Board
-
Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases
-
EV Realty Names Henrik Holland President to Accelerate National Expansion of Its Powered Properties® Platform
-
Muscogee Nation Gaming Enterprises Renews and Expands ZeroEyes Deployment Across New Properties
-
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
-
BGI Group Showcases New Technologies for Advancing Personalized Health at 2026 Global New Product Launch Event
-
LEVEL8 Rethinks Business Travel with New Hybrid Hegent Carry-On Luggage Designed for Mobility
-
Pasqal and LG CNS partner to power Next-generation AI Data centers with quantum computing
-
Syntec Optics (Nasdaq: OPTX) Secures $5M Additional Recurring Orders for Diverse Range of U.S. Defense Platforms
-
Results of Scheme Meetings and EGM
-
Fusion Fuel Expands Al Shola Gas LPG Distribution Capacity with New Bobtail Expected to Generate Approximately $1.6 Million in Annual Recurring Revenue at Target Run-Rate
-
TTM Announces Proposed Offering of $500 Million of Senior Notes Due 2034
-
Scientist Home Future Health Trial Demonstrates Significant Reduction in Eczema Symptoms using Evidence-based Nutritional Therapy
-
Percona and Coroot Partner to Bring Full-Stack Observability to Open Source Database Environments
-
Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth
-
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
-
ESGold Advances Montauban Commissioning With Arrival of Key Processing Equipment
-
SKYX Signs Merger with Leading U.S. AI Smart Home Silicon Valley Backed Company Deako, Aiming to Lead the Smart Home, Builder & Hotel Markets with Their Combined Platform Technologies
-
SKYX Signs Merger with Leading U.S. AI Smart Home Silicon Valley Backed Company Deako, Aiming to Lead the Smart Home, Builder & Hotel Markets with Their Combined Platform Technologies
-
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
-
Delaware Court of Chancery Rules Empery Digital's Board Breached Its Fiduciary Duties
-
Prime Drink Group Announces First Closing of Private Placement
-
TERRA CLEAN ENERGY CORP ANNOUNCES COMMENCEMENT OF TRENCHING AND DRILL PAD CONSTRUCTION AT THE MARYSVALE URANIUM MINES PROJECT
-
Volatus Aerospace Awarded Canadian Defence Contract for Tactical ISR Uncrewed Aircraft Systems for up to 5,000 systems
-
Bombardier's Global 8000, the World’s Fastest Civil Aircraft, Received U.K. Civil Aviation Authority (CAA) Approval to Land at London City Airport
-
Cannabis Strategic Ventures, Inc. (OTC: NUGS) Signs Letter of Intent to Acquire Adport, a Mobile Out-of-Home Advertising Technology Business
-
Cloudera and Mistral Partner to Bring Specialized, Sovereign Intelligence to Enterprise Data
-
Delaware Court of Chancery Rules Empery Digital's Board Breached Its Fiduciary Duties
-
Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival
-
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFT
-
Bombardier's Global 8000, the World’s Fastest Civil Aircraft, Received U.K. Civil Aviation Authority (CAA) Approval to Land at London City Airport
-
Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
-
Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York
-
AS Pro Kapital Grupp publishes recordings of webinars presenting the bond offering
-
Copa Holdings Announces Monthly Traffic Statistics for August 2026
-
Burning Rock Reports Second Quarter 2026 Financial Results
-
Sidetrade Launches SAFE, the Sidetrade Agentic Framework for Enterprise
-
Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment
-
Concorde International Group Announces Concorde Security as Official Security Partner of Hougang United FC
-
OSB GROUP PLC - Director/PDMR Shareholding
-
SOPRIS TECHNOLOGIES Launches Moneytoring® on Google Cloud Marketplace, Offering Comprehensive Business Observability
-
OMNI-LITE INDUSTRIES ANNOUNCES THE GRANT OF STOCK OPTIONS AND RSUs
-
Austin Roofing Completes Final 11 Buildings Concluding its Award Winning 26-building Portfolio
-
New AI Solution Helps Utilities Address More Than $180B in Capital Accounting Backlog
-
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader
-
Coppernico Signs Drill Contract for Phase 2 Drill Program at Sombrero
-
Actithera significantly strengthens leadership team and Board as Company advances towards clinical development
-
Auddia’s Discovr Radio Partners with Music Video Marketplace to Pair Independent Artists with Professional Music Videos and Guaranteed Radio Exposure
-
Anfield Advances Velvet-Wood Toward Active Dewatering with Utah Concept Approval and Outfall Reactivation Request
